© 2003 by Oxford University Press
© 2003 Oxford University Press
NEWS |
Recent Articles on HES
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.
N Engl J Med 2003;348:120114
Treatment of hypereosinophilic syndrome with imatinib mesilate.
Lancet 2002;359:15778[CrossRef][Web of Science][Medline]
.
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFR alpha-induced myeloproliferative disease.
Cancer Cell 2003;3:45969[CrossRef][Web of Science][Medline]
.
Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness.
Blood 2003;101:46606
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||